|4Feb 20, 3:47 PM ET

Charbonneau Elissa Joy 4

4 · Encompass Health Corp · Filed Feb 20, 2026

Research Summary

AI-generated summary of this filing

Updated

Encompass Health (EHC) CMO Elissa Charbonneau Receives Award of 10,798 Shares

What Happened
Elissa Joy Charbonneau, Chief Medical Officer of Encompass Health Corp (EHC), was awarded a total of 10,798 restricted shares in two grants: 8,914 shares on 2026-02-18 and 1,884 shares on 2026-02-19. Both transactions are reported as acquisitions (code A) at $0.00 per share (reported value $0), indicating these were awards of restricted stock rather than open-market purchases.

Key Details

  • Transaction dates and amounts: 2026-02-18 — 8,914 shares (award); 2026-02-19 — 1,884 shares (award). Both reported at $0.00 per share.
  • Total shares awarded: 10,798 shares.
  • Filing: Form 4 filed on 2026-02-20 (within the typical 2-business-day reporting window for insider transactions).
  • Shares owned after transaction: Not specified in the provided filing details.
  • Footnotes:
    • F1: The 2026-02-18 issuance resulted from satisfaction of performance criteria tied to a performance share unit award granted on Feb 23, 2023.
    • F2: The 2026-02-19 grant was an annual restricted stock award under the Corporation’s 2025 Omnibus Performance Incentive Plan.
  • Transaction code: A = Award/Grant of restricted stock.

Context
These were awards of restricted stock (not market purchases or option exercises). Restricted shares typically vest over time or are subject to performance conditions and may be forfeited if conditions aren't met, so they do not necessarily reflect immediate insider buying or selling intent. No sales or option exercises were reported in this filing.

Insider Transaction Report

Form 4
Period: 2026-02-18
Charbonneau Elissa Joy
Chief Medical Officer
Transactions
  • Award

    Encompass Health Common Stock

    [F1]
    2026-02-18+8,91420,872.061 total
  • Award

    Encompass Health Common Stock

    [F2]
    2026-02-19+1,88422,756.061 total
Footnotes (2)
  • [F1]This issuance of restricted stock is the result of the satisfaction of performance criteria set out in the terms of a performance share unit award made on February 23, 2023.
  • [F2]Annual award of restricted stock pursuant to the Corporation's 2025 Omnibus Performance Incentive Plan.
Signature
/s/ Patrick Darby, attorney-in-fact for Ms. Charbonneau|2026-02-20

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT